• News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • Subscribe newsletter
  • Search
  • Menu Menu
International Hospital
  • AI
  • Cardiology
  • Oncology
  • Neurology
  • Genetics
  • Orthopaedics
  • Research
  • Surgery
  • Innovation
  • Medical Imaging
  • MedTech
  • Obs-Gyn
  • Paediatrics

Archive for category: E-News

E-News

European Commission proposes to extend transition period for manufacturers to adapt to new Medical Devices Regulation

, 3 February 2023/in E-News /by panglobal

The European Commission is proposing to give more time to certify medical devices to mitigate the risk of shortages. The proposal introduces a longer transition period to adapt to new rules, as foreseen under the Medical Devices Regulation. The new deadlines depend on the medical devices’ risk class and will ensure continued access to medical […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2023/02/medical_devices-e1680868803598.png 566 900 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2023-02-03 08:20:112023-02-03 08:20:11European Commission proposes to extend transition period for manufacturers to adapt to new Medical Devices Regulation

MEDEXPRIM PARTNERS WITH OPENRAD TO PROMOTE THE SECONDARY USE OF HIGH-QUALITY REAL-WORLD IMAGING DATA

, 31 January 2023/in E-News /by panglobal
Read more
https://interhospi.com/wp-content/uploads/sites/3/2023/01/OpenRad-2022-Statistics.png 2500 800 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2023-01-31 08:00:212023-01-30 16:45:10MEDEXPRIM PARTNERS WITH OPENRAD TO PROMOTE THE SECONDARY USE OF HIGH-QUALITY REAL-WORLD IMAGING DATA

MedAlliance leads US Sirolimus DEB race: First US Patient enrolled into SELUTION SLR Coronary Sirolimus DEB Study

, 26 January 2023/in E-News /by panglobal

The first US patient has been enrolled at MedStar Washington Hospital Center in the SELUTION4ISR study evaluating SELUTION SLR™ to support FDA approval. This milestone follows Investigational Device Exemption (IDE) approval in the US in October 2022. SELUTION SLR is the first sustained limus release coronary drug-eluting balloon (DEB) to receive FDA IDE approval for In-stent […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2023/01/MedAlliance_Logo.jpg 194 400 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2023-01-26 15:37:312023-01-26 15:37:31MedAlliance leads US Sirolimus DEB race: First US Patient enrolled into SELUTION SLR Coronary Sirolimus DEB Study

Mindray defibrillators amongst the world’s first to receive EU Medical Device Regulation certification

, 23 January 2023/in E-News /by panglobal

Medical device provider Mindray has become one of the first manufacturers in the world to receive certification for its defibrillators, under the European Union’s newest Medical Device Regulation (MDR).

Read more
https://interhospi.com/wp-content/uploads/sites/3/2023/01/Naamloos-1-1.png 766 1200 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2023-01-23 14:41:102023-01-23 14:41:10Mindray defibrillators amongst the world’s first to receive EU Medical Device Regulation certification

Pie Medical Imaging announces 500th patient in the FAST III clinical trial

, 23 January 2023/in E-News /by panglobal

Pie Medical Imaging, a global leader in cardiac imaging, announced the 500th patient inclusion in the FAST III, a multi-center randomized clinical trial, which investigates the use of angiography-based vessel fractional flow reserve (CAAS vFFR) in patients undergoing coronary revascularization procedures. In this trial, a CAAS vFFR guided strategy is compared to a FFR guided […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2023/01/Naamloos-1.png 248 400 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2023-01-23 12:39:312023-01-23 12:39:31Pie Medical Imaging announces 500th patient in the FAST III clinical trial

PENTAX Medical to launch new premium video processor and endoscope series

, 23 January 2023/in E-News /by panglobal

PENTAX Medical INSPIRA™ video processor (EPK-i8020c) and the i20c endoscope generation obtain CE marks  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2023/01/221221Wurzbach0145_INSPIRA.jpg 1672 2507 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2023-01-23 11:19:152023-01-23 11:26:20PENTAX Medical to launch new premium video processor and endoscope series

Evolution in Monitor Technology

, 17 January 2023/in E-News /by panglobal
Read more
https://interhospi.com/wp-content/uploads/sites/3/2023/01/CL-S1200-von-JVCKENWOOD.jpg 600 800 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2023-01-17 10:54:202023-01-17 11:25:38Evolution in Monitor Technology

Pie Medical Imaging announces the global release of its latest echocardiography software technology, CAAS Qardia 2.0

, 13 January 2023/in E-News /by panglobal

Pie Medical Imaging (“PMI”), a global leader in cardiac imaging, today launched CAAS Qardia 2.0, a new version of their innovative echocardiography software platform. CAAS Qardia leverages artificial intelligence driven workflows for performing key clinical measurements and ease-of-access.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2023/01/CAAS.png 400 330 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2023-01-13 12:16:072023-01-13 12:16:07Pie Medical Imaging announces the global release of its latest echocardiography software technology, CAAS Qardia 2.0

Hospitals efficiently share resources and expertise across French/Belgian border by digitizing pathology with Sectra

, 13 January 2023/in E-News /by panglobal

International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has signed a digital pathology contract with the public hospitals in Roubaix and Mouscron. The two hospitals, situated on either side of the French/Belgian border, will utilize a joint Sectra digital pathology solution to enhance their collaboration. The tools provided in the digital workflow […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2023/01/Sectra-2.jpeg 533 800 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2023-01-13 11:19:042023-01-13 11:19:04Hospitals efficiently share resources and expertise across French/Belgian border by digitizing pathology with Sectra

RayStation now available at more than 200 centers in Japan

, 13 January 2023/in E-News /by panglobal

RaySearch Laboratories AB (publ) is proud to announce that the number of radiotherapy centers in Japan that are using RayStation for treatment planning has surpassed 200. In terms of number of centers, Japan is RaySearch’s second largest market.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2023/01/Raysafe.png 413 800 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2023-01-13 09:05:442023-01-13 09:05:44RayStation now available at more than 200 centers in Japan
Page 34 of 231«‹3233343536›»

Latest issue of International Hospital

April 2024

3 July 2025

EEG-powered brain computer interface enables finger-level robotic hand control

2 July 2025

Scientists identify ‘traumome’ targets for rapid emergency trauma treatment

1 July 2025

BMJ investigation reveals AstraZeneca’s billion-dollar heart drug built on flawed data

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The medical devices information portal connecting healthcare professionals to global vendors

Sign in for our newsletter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Media kit
    • Submit Press Release

Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com

PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Sign in for our newsletter

Free subscription